Procurement of immunological enzyme tests based on chemiluminescent (CLIA), immunofluorescent (ELFA) and fluorescent technology (I-Chroma)

Deadline:8 May 2026, 09:00

Tender information
Скопски
Type
Contract
Procedure
Open procedure
Ref. number
06201/2026
Estimated value
MKD 21,000,000
Duration
12 months
Procurement of immunological enzyme tests based on chemiluminescent (CLIA), immunofluorescent (ELFA) and fluorescent technology (I-Chroma)

1

Test for determining immunoglobulin M antibodies to rubella (RUBELLA IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

2

Test for determination of immunoglobulin G antibodies to toxoplasma (TOXO IgG) applicable to a device using the CLIA method or equivalent with delivery of a device for use

3

Test for determination of immunoglobulin M antibodies to toxoplasma (TOXO IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

4

Test for determination of immunoglobulin G antibodies to cytomegalovirus (CMV IgG) applicable to a device using the CLIA method or equivalent with delivery of a device for use

5

Test for determining immunoglobulin G antibodies to rubella (RUBELLA IgG) applicable to a device using the CLIA method or equivalent with delivery of a device for use

6

Test for determining Hepatitis B virus surface antigen (HBsAg) applicable to a device using the CLIA method or equivalent with delivery of a device for use

7

Test for determining immunoglobulin M antibodies to Hepatitis A virus (HAV IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

8

Test for detection of immunoglobulin M antibodies to antigen c of hepatitis B virus (ANTI HBc IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

9

HCV antigen detection test applicable to a device using a CLIA method or equivalent with delivery of a device for use

10

Test for detection of antibodies IgG to hepatitis A virus (HAV AB) applicable to a device using the CLIA method or equivalent with delivery of a device for use

11

Test for detection of total antibodies to HIV1 + HIV2 (HIV Combo) applicable to a device using the CLIA method or equivalent with delivery of a device for us

12

Test for detection of total antibodies to hepatitis B virus (HBS AB) applicable to a device using the CLIA method or equivalent with delivery of a device for use

13

Test for detection of total antibodies to hepatitis C virus (Anti HCV) applicable to a device using the CLIA method or equivalent with delivery of a device for use

14

Test for determination of immunoglobulin M antibodies to cytomegalovirus (CMV IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

15

Test for detection of total antibodies against hepatitis B internal antigen (ANTI HBc) applicable to a device using the CLIA method or equivalent with delivery of a device for use

16

Test for the detection of VCA IgG antibodies to Epstein Barr virus (EBV VCAIgG) applicable to a device using the CLIA method or equivalent with delivery of a device for use

17

Test for the detection of VCA IgM antibodies to Epstein Barr virus (EBV VCA IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

18

Test for determination of immunoglobulin G antibodies to Herpes virus 1 (HSV1IgG) applicable to a device using the CLIA method or equivalent with delivery of a device for use

19

Test for determination of immunoglobulin G antibodies to Herpes virus 2 (HSV2IgG) applicable to a device using the CLIA method or equivalent with delivery of a device for use

20

Test for determination of immunoglobulin M antibodies to Herpes virus 1 (HSV1 IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

21

Test for determination of immunoglobulin M antibodies to Herpes virus 2 (HSV2IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

22

Test for determining immunoglobulin M antibodies to Hepatitis E virus (HEV IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

23

Test for determining hepatitis B virus antigen (HBeAg) applicable to a device using the CLIA method or equivalent with delivery of a device for use

24

Test for determining hepatitis B virus antigen (HBeAg) applicable to a device using the CLIA method or equivalent with delivery of a device for use

25

Test for detection of age of immunoglobulin G antibodies to Toxoplasma (TOXO IgG avidity) applicable to a device using the CLIA method or equivalent with delivery of a device for use

26

Test for determining the age of immunoglobulin G antibodies to Cytomegalovirus (CMV IgG avidity) applicable to a device using the CLIA method or equivalent with delivery of a device for use

27

Test for determination of immunoglobulin M antibodies (IgM) to Helicobacter pylori (H. pylori) applicable to a device using the CLIA method or equivalent with delivery of a device for use

28

Test for the determination of immunoglobulin G antibodies (IgG) to Helicobacter pylori (H. pylori) applicable to a device using the CLIA method or equivalent with delivery of a device for use

29

Test for determining TSH applicable to a device using the CLIA method or equivalent with delivery of a device for use

30

Test for determining FT3 applicable to a device using a CLIA method or equivalent with delivery of a device for use

31

Test for determining FT4 applicable to a device using a CLIA method or equivalent with delivery of a device for use

32

Anti TPO test applicable to a device using a CLIA method or equivalent with delivery of a device for use

33

Calcitonin determination test applicable to a device using a CLIA method or equivalent with delivery of a device for use

34

Osteocalcin test applicable to a device using a CLIA method or equivalent with delivery of a device for use

35

OH-25 Vit D determination test applicable to a device using a CLIA method or equivalent with delivery of a device for use

36

Test for determining Intact PTH applicable to a device using a CLIA method or equivalent with delivery of a device for use

37

Test for determination of β - CTx applicable to a device using a CLIA method or equivalent with delivery of a device for use

38

Test for determining immunoglobulin M antibodies for Dengue virus (Denque IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

39

Test for determining immunoglobulin G antibodies to Dengue virus (Denque IgG) applicable to a device using the CLIA method or equivalent with delivery of a device for use

40

Test for determining immunoglobulin M antibodies to SARS CoV-2 virus (SARS CoV-2 IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

41

Test for determining immunoglobulin G antibodies to SARS CoV-2 virus (SARS CoV-2 IgG) applicable to a device using a CLIA method or equivalent with delivery of a device for use

42

Test for determination of immunoglobulin M antibodies to Coxackie virus B (Coxackie B IgM) applicable to a device using the CLIA method or equivalent with delivery of a device for use

43

Listeria Duo test applicable to a device using the ELFA method or equivalent with delivery of a device for use

44

Test for detection of Campylobacter applicable to a device using the ELFA method or equivalent with delivery of a device for use

45

Test for detection of Vidas E.Coli O157:H7 applicable to a device using the ELFA method or equivalent with delivery of a device for use

46

Test for detection of Vidas Staph.Enterotoxin2 applicable to a device using the ELFA method or equivalent with delivery of a device for use

47

Test for detection of immunoglobulin G antibodies to rubella (RUBELLA IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

48

Test for detection of immunoglobulin G antibodies to toxoplasma (TOXO IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

49

Test for detection of immunoglobulin M antibodies to rubella (RUBELLA IgM) applicable to a device using the ELFA method or equivalent with delivery of a device for use

50

Test for detection of immunoglobulin M antibodies to cytomegalovirus (CMV IgM) applicable to a device using the ELFA method or equivalent with delivery of a device for use

51

Test for detection of immunoglobulin M antibodies to toxoplasma (TOXO IgM) applicable to a device using the ELFA method or equivalent with delivery of a device for use

52

Test for detection of immunoglobulin G antibodies to mumps virus (Anti Mumps IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

53

Test for detection of total antibodies to hepatitis A virus (Anti HAV Total) applicable to a device using the ELFA method or equivalent with delivery of a device for use

54

Test for detection of immunoglobulin G antibodies to cytomegalovirus (CMV IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

55

Test for detection of hepatitis B virus membrane (surface) antigen (HBsAg) applicable to a device using the ELFA method or equivalent with delivery of a device for use

56

Test for detection of immunoglobulin G antibodies to Lyme borreliosis (Anti Lyme IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

57

Test for detection of immunoglobulin G antibodies to measles virus (Anti Measles IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

58

Test for detection of p24 antigen of human immunodeficiency virus (HIV p24 antigen) applicable to a device using the ELFA method or equivalent with delivery of a device for use

59

Test for detection of immunoglobulin M antibodies to hepatitis A virus (Anti HAV IgM) applicable to a device using the ELFA method or equivalent with delivery of a device for use

60

Test for detection of total antibodies against hepatitis B internal antigen (ANTI HBc) applicable to a device using the ELFA method or equivalent with delivery of a device for use

61

Test for detection of hepatitis B virus antigen and antibodies to antigen (HBeAg/anti HBe) applicable to a device using the ELFA method or equivalent with delivery of a device for use

62

Test for detection of immunoglobulin M antibodies to antigen C of hepatitis B virus (ANTI HBc IgM) applicable to a device using the ELFA method or equivalent with delivery of a device for use

63

Test for detection of immunoglobulin G antibodies to Varicella Zoster virus (Anti Varicella zoster IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

64

Test for detection of total antibodies against hepatitis B membrane (surface) antigen (ANTI HBs) applicable to a device using the ELFA method or equivalent with delivery of a device for use

65

Test for detection of immunoglobulin G antibodies to the nuclear protein of Epstein Barr virus (Anti EBV EBNA IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

66

Test for detection of immunoglobulin M antibodies to viral capsid antigen of Epstein Barr virus (Anti EBV VCA IgM) applicable to a device using the ELFA method or equivalent with delivery of a device for use

67

Test for detection of immunoglobulin G antibodies to viral capsid antigen of Epstein Barr virus (Anti EBV VCA IgG) applicable to a device using the ELFA method or equivalent with delivery of a device for use

68

Test for simultaneous detection of total antibodies and p24 antigen of human immunodeficiency virus (Anti HIV / p 24 antigen) applicable to a device using the ELFA method or equivalent with delivery of a device for use

69

Test for quality control (Quality Control) applicable to a device using the ELFA method or equivalent with delivery of the device for use

70

Test for detection of Salmonella applicable to a device using the ELFA method or equivalent with delivery of a device for use

71

Test for detection of total antibodies to hepatitis C virus (Anti HCV) applicable to a device using the ELFA method or equivalent with delivery of a device for use

72

Test for detection of immunoglobulin M antibodies to Lyme borreliosis (Anti lyme IgM) applicable to a device using the ELFA method or equivalent with delivery of a device for use

73

Test for detection of immunoglobulin G antibodies (IgG) to Helicobacter pylori (H. pylori) applicable to a device using the ELFA method or equivalent with delivery of a device for use

74

Test for detection of age of immunoglobulin G antibodies to Toxoplasma (TOXO IgG avidity) applicable to a device using the ELFA method or equivalent with delivery of a device for use

75

Test for detection of age of immunoglobulin G antibodies to Cytomegalovirus (CMV IgG avidity) applicable to a device using the ELFA method or equivalent with delivery of a device for use

76

i-Chroma CRP or equivalent with delivery of device for use

77

i-CHROMA ASO or equivalent with delivery of a device for use

78

i-CHROMA H.PYLORY AG or equivalent with delivery of a device for use

79

i-CHROMA DENQUEIgG/IgM or equivalent with delivery of device for use

80

i-CHROMA DENQUE NS1AG or equivalent with delivery of a device for use

Buyer
PHI Institute of Public Health of Republic of North Macedonia Skopje
buyer-email@mail.com
organization number

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
Deadline passed
Important dates
14 Apr - Publication date
8 May - Deadline
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.